Business · 18/10/20021 min read
FDA Announces Draft Guidance for Industry on Use of Human Blood and Blood Components
The FDA has released a draft document outlining acceptable practices for the use of human blood and blood components, which will help manufacturers comply with FDA regulations and label their products correctly.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →